A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
Clinical trial NCT05970640 · COMPLETED
Trial details
- NCT number
- NCT05970640
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-14
- Primary completion
- 2024-10-31
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.